Journal DOI 10.68956/dyh5-kwte

Creative Commons source reading · Headache and migraine

Microglia P2X4R-BDNF signalling contributes to central sensitization in a recurrent nitroglycerin-induced chronic migraine model.

Ting Long; Wei He; Qi Pan; Shanshan Zhang; Dunke Zhang; Guangcheng Qin; Lixue Chen; Jiying Zhou

Originally published in The journal of headache and pain · 2020-01-14

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Background According to our previous study, microglia P2X4 receptors (P2X4Rs) play a pivotal role in the central sensitization of chronic migraine (CM). However, the molecular mechanism that underlies the crosstalk between microglia P2X4Rs and neurons of the trigeminal nucleus caudalis (TNC) is not fully understood. Therefore, the aim of this study is to examine the exact P2X4Rs signalling pathway in the development of central sensitization in a CM animal model. Methods We used an animal model with recurrent intermittent administration of nitroglycerin (NTG), which closely mimics CM. NTG-induced basal mechanical and thermal hypersensitivity were evaluated using a von Frey filament test and an increasing-temperature hot plate apparatus (IITC). We detected P2X4Rs, brain-derived neurotrophic factor (BDNF) and phosphorylated p38 mitogen-activated protein kinase (p-p38-MAPK) expression profiles in the TNC. We investigated the effects of a P2X4R inhibitor (5-BDBD) and an agonist (IVM) on NTG-induced hyperalgesia and neurochemical changes as well as on the expression of p-p38-MAPK and BDNF.

Discussion

The present data in our study indicate that repeat NTG stimulation can induce mechanical and thermal hypersensitivity and an increase in p-ERK and CGRP release. The observed behavioural and neurochemical changes can be interpreted as a central sensitization phenomenon. Moreover, in these recurrent NTG injection mice, we found an enhancement of P2X4 and BDNF expression levels in the TNC. Negative P2X4-BDNF modulators can reverse hyperalgesia and the change in migraine biomarkers induced by repeated NTG injection.

Conclusions

Our findings indicate that the P2X4Rs may contribute to central sensitization after repeated NTG stimulation. Pharmacological blockade of P2X4Rs evidently prevents migraine-associated hyperalgesia, CGRP release and ERK phosphorylation. We suggest that the effectiveness of P2X4Rs in migraine progression may be due to the promotion of the synthesis and release of BDNF in microglia. BDNF is a key molecule mediating microglia-neuron signalling. Therefore, the modulation of P2X4R-BDNF signalling function may be a novel therapeutic avenue for the treatment of chronic migraine.

Editorial reading guide

  • Which patient population and reference standard did the authors use?
  • Was the finding validated in a separate cohort, and how might patient selection affect it?